COLE PHARMACEUTICALS

{
  "facts": [
    {
      "type": "filing",
      "quote": "TRIBUNAL DE L\u0027ENTREPRISE 28 MAI 2026",
      "value": "2026-05-28",
      "object": null,
      "subject": "e1"
    },
    {
      "type": "publication",
      "quote": "Bijlagen bij het Belgisch Staatsblad - 08/06/2026 - Annexes du Moniteur belge",
      "value": "2026-06-08",
      "object": null,
      "subject": "e1"
    },
    {
      "type": "general_meeting",
      "quote": "D\u0027un proc\u00E8s-verbal d\u0027assembl\u00E9e g\u00E9n\u00E9rale extraordinaire dress\u00E9 par le notaire Laurent WETS, \u00E0 Uccle, le 23 d\u00E9cembre 2025",
      "value": "2025-12-23",
      "object": null,
      "subject": "e1"
    },
    {
      "type": "notarial_deed",
      "quote": "D\u0027un proc\u00E8s-verbal d\u0027assembl\u00E9e g\u00E9n\u00E9rale extraordinaire dress\u00E9 par le notaire Laurent WETS, \u00E0 Uccle, le 23 d\u00E9cembre 2025",
      "value": "2025-12-23",
      "object": "e2",
      "subject": "e1"
    },
    {
      "type": "auditor_waiver",
      "quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale a dispens\u00E9 le Pr\u00E9sident de donner lecture du rapport \u00E9tabli par l\u0027organe d\u0027administration, le 15 d\u00E9cembre 2025",
      "value": null,
      "object": null,
      "subject": "e1"
    },
    {
      "type": "auditor_report",
      "quote": "Le rapport du R\u00E9viseur d\u0027entreprises, Monsieur DEMONCEAU David, exer\u00E7ant sa fonction dans la Soci\u00E9t\u00E9 \u00E0 Responsabilit\u00E9 Limit\u00E9e \u003C AXYLIUM AUDIT - LIEGE \u00BB",
      "value": null,
      "object": "e4",
      "subject": "e1"
    },
    {
      "type": "approval",
      "quote": "L\u0027assembl\u00E9e a approuv\u00E9 ces deux rapports.",
      "value": null,
      "object": null,
      "subject": "e1"
    },
    {
      "type": "capital_increase",
      "quote": "L\u0027op\u00E9ration consiste en une augmentation des capitaux propres de 1.589.000 \u20AC par apports de cr\u00E9ances et de droits de propri\u00E9t\u00E9 intellectuelle",
      "value": {
        "amount": 1589000,
        "currency": "EUR",
        "share_class": "D",
        "share_premium": 0,
        "shares_issued": 659549
      },
      "object": null,
      "subject": "e1"
    },
    {
      "type": "share_distribution",
      "quote": "1. A La Soci\u00E9t\u00E9 \u00E0 Responsabilit\u00E9 Limit\u00E9e \u003C Sodintec Finances \u00BB, pr\u00E9cit\u00E9e, qui a d\u00E9clar\u00E9 accepter, trente-cing mille quatre-vingt-huit actions, ci: 35.088",
      "value": {
        "class": "D",
        "shares": 35088,
        "consideration": {
          "type": "cr\u00E9ances",
          "amount": 60000,
          "currency": "EUR"
        }
      },
      "object": "e6",
      "subject": "e1"
    },
    {
      "type": "share_distribution",
      "quote": "2. A La Soci\u00E9t\u00E9 \u00E0 Responsabilit\u00E9 Limit\u00E9e \u00AB Spreds Finance \u003E, qui a d\u00E9clar\u00E9 accepter, deux mille cent cing cents actions, ci: 2.105",
      "value": {
        "class": "D",
        "shares": 2105,
        "consideration": {
          "type": "cr\u00E9ances",
          "amount": 4760,
          "currency": "EUR"
        }
      },
      "object": "e7",
      "subject": "e1"
    },
    {
      "type": "share_distribution",
      "quote": "3. A la Soci\u00E9t\u00E9 Anonyme \u003C C\u0026N Holding \u00BB, pr\u00E9cit\u00E9e, qui a d\u00E9clar\u00E9 accepter, nonante-deux mille cent quatre-vingt-quatre actions, ci: 92.184",
      "value": {
        "class": "D",
        "shares": 92184,
        "consideration": {
          "type": "cr\u00E9ances",
          "amount": 200000,
          "currency": "EUR"
        }
      },
      "object": "e8",
      "subject": "e1"
    },
    {
      "type": "share_distribution",
      "quote": "4. A Monsieur DELEUZE St\u00E9phane, pr\u00E9nomm\u00E9, qui a d\u00E9clar\u00E9 accepter, nonante mille cent treize actions, ci : 90.113",
      "value": {
        "class": "D",
        "shares": 90113,
        "consideration": {
          "type": "cr\u00E9ances",
          "amount": 200000,
          "currency": "EUR"
        }
      },
      "object": "e9",
      "subject": "e1"
    },
    {
      "type": "share_distribution",
      "quote": "5. A Monsieur B\u00C9NARD Andr\u00E9, pr\u00E9nomm\u00E9, qui a d\u00E9clar\u00E9 accepter, soixante mille cent soixante-deux actions, ci: 60.172",
      "value": {
        "class": "D",
        "shares": 60172,
        "consideration": {
          "type": "cr\u00E9ances",
          "amount": 150000,
          "currency": "EUR"
        }
      },
      "object": "e10",
      "subject": "e1"
    },
    {
      "type": "share_distribution",
      "quote": "6. A Monsieur PHILIPS Mario, pr\u00E9nomm\u00E9, qui a d\u00E9clar\u00E9 accepter, cent onze mille cing cent quatre-vingt-six (111.586) actions, ci: 111.586",
      "value": {
        "class": "D",
        "shares": 111586,
        "consideration": {
          "type": "cr\u00E9ances",
          "amount": 200000,
          "currency": "EUR"
        }
      },
      "object": "e11",
      "subject": "e1"
    },
    {
      "type": "share_distribution",
      "quote": "7. A la Soci\u00E9t\u00E9 Anonyme Phytomed, pr\u00E9cit\u00E9e, qui a d\u00E9clar\u00E9 accepter, deux cent soixante-huit mille trois cent une actions, ci: 268.301",
      "value": {
        "class": "D",
        "shares": 268301,
        "consideration": {
          "type": "droits de propri\u00E9t\u00E9 intellectuelle",
          "amount": 775000,
          "currency": "EUR"
        }
      },
      "object": "e12",
      "subject": "e1"
    },
    {
      "type": "statute_amendment",
      "quote": "l\u0027assembl\u00E9e g\u00E9n\u00E9rale a d\u00E9clar\u00E9 et d\u00E9cid\u00E9 de remplacer les articles 5, 7 et 11 des statuts par les textes suivants",
      "value": null,
      "object": null,
      "subject": "e1"
    },
    {
      "type": "governance_rule",
      "quote": "l\u0027assembl\u00E9e g\u00E9n\u00E9rale a d\u00E9cid\u00E9 de pr\u00E9voir, dans les statuts, la d\u00E9l\u00E9gation \u00E0 l\u0027organe d\u0027administration du pouvoir de proc\u00E9der, dans les limites des articles 5:142 et 5:143 dudit Code \u00E0 des distributions provenant du b\u00E9n\u00E9fice de l\u0027exercice en cours ou du b\u00E9n\u00E9fice de l\u0027exercice pr\u00E9c\u00E9dent tant que les comptes annuels de cet exercice n\u0027ont pas \u00E9t\u00E9 approuv\u00E9s",
      "value": null,
      "object": null,
      "subject": "e1"
    },
    {
      "type": "reserve_release",
      "quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale a d\u00E9cid\u00E9 de transf\u00E9rer la totalit\u00E9 des pertes report\u00E9es au compte apports disponibles.",
      "value": null,
      "object": null,
      "subject": "e1"
    },
    {
      "type": "act_object",
      "quote": "Objet de l\u0027acte: Apports en nature - Modification des statuts",
      "value": "Apports en nature - Modification des statuts",
      "object": null,
      "subject": null
    }
  ],
  "act_meta": {
    "model_id": 40,
    "extractor": "open-capture-27b-v3",
    "ocr_chars": 18831,
    "truncated": false,
    "needs_verify": true
  },
  "entities": [
    {
      "id": "e1",
      "kbo": "0671.904.152",
      "kind": "company",
      "name": "COLE PHARMACEUTICALS",
      "attrs": {
        "vat": "BE0671.904.152",
        "seat": "1435 Mont-Saint-Guibert, Rue Andr\u00E9 Dumont, 7",
        "legal_form": "Soci\u00E9t\u00E9 \u00E0 Responsabilit\u00E9 Limit\u00E9e",
        "short_name": "Cole Pharma"
      }
    },
    {
      "id": "e2",
      "kbo": null,
      "kind": "person",
      "name": "Laurent WETS",
      "attrs": {
        "role": "notaire"
      }
    },
    {
      "id": "e3",
      "kbo": null,
      "kind": "person",
      "name": "V\u00E9ronique Bonehill",
      "attrs": {
        "role": "notaire"
      }
    },
    {
      "id": "e4",
      "kbo": null,
      "kind": "person",
      "name": "DEMONCEAU David",
      "attrs": {
        "role": "R\u00E9viseur d\u0027entreprises"
      }
    },
    {
      "id": "e5",
      "kbo": null,
      "kind": "org",
      "name": "AXYLIUM AUDIT - LIEGE",
      "attrs": {
        "legal_form": "Soci\u00E9t\u00E9 \u00E0 Responsabilit\u00E9 Limit\u00E9e"
      }
    },
    {
      "id": "e6",
      "kbo": "0507.657.517",
      "kind": "company",
      "name": "Sodintec Finances",
      "attrs": {
        "vat": "BE0507.657.517",
        "seat": "1200 Woluwe-Saint-Lambert Bruxelles, Rue Lola Bobesco, 2, bo\u00EEte 13",
        "legal_form": "Soci\u00E9t\u00E9 \u00E0 Responsabilit\u00E9 Limit\u00E9e"
      }
    },
    {
      "id": "e7",
      "kbo": "0538.839.354",
      "kind": "company",
      "name": "Spreds Finance",
      "attrs": {
        "vat": "BE0538.839.354",
        "seat": "1000 Bruxelles, Rue des Colonies, 11",
        "legal_form": "Soci\u00E9t\u00E9 \u00E0 Responsabilit\u00E9 Limit\u00E9e"
      }
    },
    {
      "id": "e8",
      "kbo": "0866.337.880",
      "kind": "company",
      "name": "C\u0026N Holding",
      "attrs": {
        "vat": "BE0866.337.880",
        "seat": "1910 Kampenhout, Terloonststraat, 22",
        "legal_form": "Soci\u00E9t\u00E9 Anonyme"
      }
    },
    {
      "id": "e9",
      "kbo": null,
      "kind": "person",
      "name": "DELEUZE St\u00E9phane Camille Paul Arthur",
      "attrs": {
        "domicile": "London (Royaume-Uni-Grande Bretagne), Lawn Lane, 10, Apartment 1"
      }
    },
    {
      "id": "e10",
      "kbo": null,
      "kind": "person",
      "name": "B\u00C9NARD Andr\u00E9 Marcel Victor",
      "attrs": {
        "domicile": "Woluwe-Saint-Pierre (1150 Bruxelles), Avenue des Cormorans, 38"
      }
    },
    {
      "id": "e11",
      "kbo": null,
      "kind": "person",
      "name": "PHILIPS Mario",
      "attrs": {
        "domicile": "9340 Lede, Erfken, 6"
      }
    },
    {
      "id": "e12",
      "kbo": "1031.897.777",
      "kind": "company",
      "name": "Phytomed",
      "attrs": {
        "vat": "BE 1031.897.777",
        "seat": "9911 Troisvierges (Grand-Duch\u00E9 du Luxembourg), Rue de Drinklange, 2",
        "rcs_lux": "B184202",
        "legal_form": "Soci\u00E9t\u00E9 Anonyme de droit luxembourgeois"
      }
    }
  ]
}

{
  "events": [
    {
      "kind": "zetel_transfer",
      "seat_type": "statutaire",
      "new_address": {
        "city": "Mont-Saint-Guibert",
        "region": null,
        "street": "rue Andr\u00E9 Dumont",
        "country": "BE",
        "postcode": "1435",
        "box_number": null,
        "street_number": "7"
      },
      "old_address": {
        "city": "Grez-Doiceau",
        "region": null,
        "street": "Champ de Maubroux",
        "country": "BE",
        "postcode": "1390",
        "box_number": null,
        "street_number": "21"
      },
      "effective_date": "2024-11-12",
      "evidence_quote": "Le conseil d\u0027administration d\u00E9cide de transf\u00E9rer \u00E0 dater de ce jour le si\u00E8ge de la Soci\u00E9t\u00E9 \u00E0 l\u0027adresse suivante: rue Andr\u00E9 Dumont 7, 1435 Mont-Saint- Guibert."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0671.904.152",
    "name_full": "COLE PHARMACEUTICALS, EN ABREGE : COLE PHARMA",
    "legal_form": "SRL"
  }
}

{
  "events": [
    {
      "kind": "capital_increase",
      "amount": 581409.84,
      "currency": "EUR",
      "after_eur": null,
      "delta_eur": 581409.84,
      "before_eur": null,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2023-08-30",
      "evidence_quote": "Total apport 581.409,84",
      "contribution_type": "in_kind"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0671.904.152",
    "name_full": "COLE PHARMACEUTICALS, EN ABREGE : COLE PHARMA",
    "legal_form": "SRL"
  }
}

{
  "events": [
    {
      "kind": "commissaris_in",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "Adil El Filali",
        "address": null,
        "birth_date": null
      },
      "evidence_quote": "Le conseil propose la nomination de M. Adil El Filali, Reviseur d\u0027entreprise associ\u00E9-fondateur du bureau CLC SRL (Contr\u00F4le L\u00E9gal des Comptes \u0026 Consultance), comme commissaire aux comptes avec un mandat de 3 ans. L\u0027assembl\u00E9e approuve ces deux propositions \u00E0 l\u0027unanimit\u00E9 des voix."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0671.904.152",
    "name_full": "COLE PHARMACEUTICALS, EN ABREGE : COLE PHARMA",
    "legal_form": "SRL"
  }
}

{
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "statute_change": {
    "name_change": false,
    "seat_change": false,
    "object_change": false,
    "effective_date": "2022-06-10",
    "legal_form_change": false
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0671.904.152",
    "name_full": "COLE PHARMACEUTICALS, EN ABREGE : COLE PHARMA",
    "legal_form": "SRL"
  },
  "signature_regime": null,
  "special_mandates": [],
  "governance_change": {
    "admin_delegated_added": []
  }
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Mar\u00EDo Philips",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2021-01-18",
      "evidence_quote": "Le conseil d\u0027administartion acte la d\u00E9mission, \u00E0 dater du 18 janvier 2021, de Mr Mar\u00EDo Philips"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0671.904.152",
    "name_full": "COLE PHARMACEUTICALS, EN ABREGE : COLE PHARMA",
    "legal_form": "SRL"
  }
}

{
  "events": [
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Mario Philips",
        "address": null,
        "birth_date": null
      },
      "evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale nomme en tant qu\u0027administrateur pour une dur\u00E9e de 3 ans: - Mr Mario Philips domicili\u00E9 Erfken, 6 \u00E0 9340 Lede n\u00E9 le 17 juillet 1969 \u00E0 Aalst (n.n.69.07.17-427-76)"
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Guillaume de Viron",
        "address": null,
        "birth_date": null
      },
      "evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale nomme en tant qu\u0027administrateur pour une dur\u00E9e de 3 ans: ... - Mr Guillaume de Viron domicili\u00E9 Chemin du Bois de Villers, 8b \u00E0 1325 Chaumonx-Gistoux, n\u00E9 le 27 ao\u00FBt 1977 \u00E0 Ixelles (n.n. 77.08.25-211.33)"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0671.904.152",
    "name_full": "COLE PHARMACEUTICALS, EN ABREGE : COLE PHARMA",
    "legal_form": "SRL"
  }
}

{
  "events": [
    {
      "kind": "capital_increase",
      "amount": 438400.0,
      "currency": "EUR",
      "after_eur": 457000.0,
      "delta_eur": 438400.0,
      "before_eur": 18600.0,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2019-12-23",
      "evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide d\u0027augmenter le capital, \u00E0 concurrence de quatre cent trente-huit mille quatre cents euros (438.400,00.EUR), pour le porter de dix-huit mille six cents euros (18.600,00.EUR), \u00E0 quatre cent cinquante-sept mille euros (457.000,00.EUR), par la cr\u00E9ation de quatre cent trente-huit mille quatre cents parts sociales nouvelles... Ces parts nouvelles seront imm\u00E9diatement souscrites en esp\u00E8ces et enti\u00E8rement lib\u00E9r\u00E9es \u00E0 la souscription.",
      "contribution_type": "cash"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0671.904.152",
    "name_full": "COLE PHARMACEUTICALS, EN ABREGE : COLE PHARMA",
    "legal_form": "SPRL"
  }
}

{
  "events": [
    {
      "kind": "share_transfer",
      "amount": 62,
      "currency": null,
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "amount_type": "onbekend",
      "effective_date": "2017-06-13",
      "evidence_quote": "Monsieur Giovanni NAVALESI c\u00E8de ses 62 parts sociales \u00E0 Monsieur Claude LUBICKI (31 parts) et \u00E0 Monsieur Jean-Marie VANDEPLAS (31 parts).",
      "contribution_type": null
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0671.904.152",
    "name_full": "COLE PHARMACEUTICALS, EN ABREGE : COLE PHARMA",
    "legal_form": "SPRL"
  }
}

{
  "kind": "oprichting",
  "seat": "Avenue Lat\u00E9rale 143 bte A 10, 1180 Uccle",
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "founders": [
    {
      "org": null,
      "kind": "natural_person",
      "person": {
        "dob": "1956-03-06",
        "name": "VANDEPLAS Jean-Marie Fernand Joseph",
        "niss": null,
        "address": "1390 Grez-Doiceau, Champ de Maubroux, 21"
      },
      "share_class": "ordinary",
      "partner_role": null,
      "holder_org_kbo": null,
      "holder_org_name": null,
      "contribution_type": "cash",
      "amount_paid_in_eur": 3100,
      "holder_person_name": "VANDEPLAS Jean-Marie Fernand Joseph",
      "is_subscriber_only": false,
      "n_shares_subscribed": 62,
      "amount_subscribed_eur": 6200,
      "is_anonymous_silent_partner": false
    },
    {
      "org": null,
      "kind": "natural_person",
      "person": {
        "dob": "1960-05-25",
        "name": "LUBICKI Claude",
        "niss": null,
        "address": "Uccle (1180 Bruxelles), Avenue Lat\u00E9rale, 143 \u2013 A10"
      },
      "share_class": "ordinary",
      "partner_role": null,
      "holder_org_kbo": null,
      "holder_org_name": null,
      "contribution_type": "cash",
      "amount_paid_in_eur": 3100,
      "holder_person_name": "LUBICKI Claude",
      "is_subscriber_only": false,
      "n_shares_subscribed": 62,
      "amount_subscribed_eur": 6200,
      "is_anonymous_silent_partner": false
    },
    {
      "org": null,
      "kind": "natural_person",
      "person": {
        "dob": "1959-03-28",
        "name": "NAVALESI Giovanni",
        "niss": null,
        "address": "Firenze (Italie), Via Reginaldo Giuliani, 287"
      },
      "share_class": "ordinary",
      "partner_role": null,
      "holder_org_kbo": null,
      "holder_org_name": null,
      "contribution_type": "cash",
      "amount_paid_in_eur": 3100,
      "holder_person_name": "NAVALESI Giovanni",
      "is_subscriber_only": false,
      "n_shares_subscribed": 62,
      "amount_subscribed_eur": 6200,
      "is_anonymous_silent_partner": false
    }
  ],
  "capital_eur": 18600,
  "subject_company": {
    "kbo": "0671.904.152",
    "name_full": "COLE PHARMACEUTICALS",
    "legal_form": "SNC"
  },
  "initial_directors": [],
  "incorporation_date": "2017-02-27",
  "post_incorporation_mandates": []
}